소화관 출혈 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 소화관 부위별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Gastrointestinal Bleeding Treatment Market, valued at USD 562.44 Million in 2024, is projected to experience a CAGR of 5.88% to reach USD 792.34 Million by 2030. The Global Gastrointestinal Bleeding Treatment Market focuses on medical interventions designed to halt or manage blood loss originating within the gastrointestinal tract, encompassing the esophagus, stomach, small intestine, large intestine, and rectum, alongside addressing underlying causes and preventing complications.

Key Market Drivers

The increasing prevalence of gastrointestinal disorders significantly drives the Global Gastrointestinal Bleeding Treatment Market. Conditions such as peptic ulcers, gastritis, and colorectal cancer inherently carry a risk of bleeding, necessitating medical intervention. As the global burden of these diseases grows, the demand for effective diagnostic and therapeutic solutions for gastrointestinal bleeding escalates.

Key Market Challenges

The substantial cost associated with advanced diagnostic and therapeutic devices and procedures presents a significant challenging factor within the Global Gastrointestinal Bleeding Treatment Market. This financial impediment directly restrains market expansion by limiting the accessibility and widespread adoption of innovative, highly effective interventions, particularly in healthcare systems with constrained budgets and in developing nations. The high initial capital expenditure required for sophisticated endoscopes, specialized hemostatic instruments, and associated processing units often exceeds the financial capacity of numerous healthcare providers, hindering their ability to invest in these critical technologies.

Key Market Trends

The expansion of telehealth and remote monitoring in gastrointestinal bleeding management represents a significant evolution in healthcare delivery. This trend moves beyond traditional in-person visits to offer continuous patient oversight and enhanced post-discharge care. Telehealth platforms facilitate virtual consultations and enable remote patient monitoring through digital health tools, which supports timely interventions and improves patient engagement by providing convenience and accessibility, especially for individuals in remote areas or those facing mobility challenges.

Key Market Players

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC
• Pfizer Inc.

Report Scope:

In this report, the Global Gastrointestinal Bleeding Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Bleeding Treatment Market, By Product:

• Closure Devices
• Endoscopic Hemostatic Devices
• Others

Gastrointestinal Bleeding Treatment Market, By GI Tract Division:

• Upper GI Tract
• Lower GI Tract

Gastrointestinal Bleeding Treatment Market, By End Users:

• Hospital/Clinics
• Ambulatory Surgical Centres
• Others

Gastrointestinal Bleeding Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gastrointestinal Bleeding Treatment Market.

Available Customizations:

Global Gastrointestinal Bleeding Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Bleeding Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Closure Devices, Endoscopic Hemostatic Devices, Others)
  • 5.2.2. By GI Tract Division (Upper GI Tract, Lower GI Tract)
  • 5.2.3. By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Gastrointestinal Bleeding Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By GI Tract Division
  • 6.2.3. By End Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By GI Tract Division
      • 6.3.1.2.3. By End Users
  • 6.3.2. Canada Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By GI Tract Division
      • 6.3.2.2.3. By End Users
  • 6.3.3. Mexico Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By GI Tract Division
      • 6.3.3.2.3. By End Users

7. Europe Gastrointestinal Bleeding Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By GI Tract Division
  • 7.2.3. By End Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By GI Tract Division
      • 7.3.1.2.3. By End Users
  • 7.3.2. France Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By GI Tract Division
      • 7.3.2.2.3. By End Users
  • 7.3.3. United Kingdom Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By GI Tract Division
      • 7.3.3.2.3. By End Users
  • 7.3.4. Italy Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By GI Tract Division
      • 7.3.4.2.3. By End Users
  • 7.3.5. Spain Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By GI Tract Division
      • 7.3.5.2.3. By End Users

8. Asia Pacific Gastrointestinal Bleeding Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By GI Tract Division
  • 8.2.3. By End Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By GI Tract Division
      • 8.3.1.2.3. By End Users
  • 8.3.2. India Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By GI Tract Division
      • 8.3.2.2.3. By End Users
  • 8.3.3. Japan Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By GI Tract Division
      • 8.3.3.2.3. By End Users
  • 8.3.4. South Korea Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By GI Tract Division
      • 8.3.4.2.3. By End Users
  • 8.3.5. Australia Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By GI Tract Division
      • 8.3.5.2.3. By End Users

9. Middle East & Africa Gastrointestinal Bleeding Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By GI Tract Division
  • 9.2.3. By End Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By GI Tract Division
      • 9.3.1.2.3. By End Users
  • 9.3.2. UAE Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By GI Tract Division
      • 9.3.2.2.3. By End Users
  • 9.3.3. South Africa Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By GI Tract Division
      • 9.3.3.2.3. By End Users

10. South America Gastrointestinal Bleeding Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By GI Tract Division
  • 10.2.3. By End Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By GI Tract Division
      • 10.3.1.2.3. By End Users
  • 10.3.2. Colombia Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By GI Tract Division
      • 10.3.2.2.3. By End Users
  • 10.3.3. Argentina Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By GI Tract Division
      • 10.3.3.2.3. By End Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gastrointestinal Bleeding Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Olympus Corporation
• 15.3. CONMED Corporation
• 15.4. Ovesco Endoscopy AG
• 15.5. Erbe Elektromedizin GmbH
• 15.6. Steris Plc
• 15.7. US Medical Innovations, LLC
• 15.8. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer